Results 71 to 80 of about 26,059 (187)
Фармакоэкономика, 2015 VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»
doaj +2 more sources
ClinicoEconomics and Outcomes ResearchWenjuan Wang,1,* Dachuang Zhou,1,* Kejia Zhou,1 Di Zhang,1 Hao Li,1 Hongliu Zhang,1 Xin Jiang,1 Ruihua Wang,1 Xi Wang,2 Wenxi Tang1 1Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, Jiangsu ...
Wang W +9 more
doaj
Pharmacoeconomics Education in the Middle East and North Africa Region: A Web-Based Research.
Value in Health Regional Issues, 2021 S. Farid, D. Baines
semanticscholar +1 more source
Navigating Healthcare Economics Optimizing Therapeutic Efficacy and Cost with Pharmacoeconomics
Journal of Pharmacoeconomics and Pharmaceutical ManagementBackground: In today's healthcare landscape, escalating costs underscore the pressing need for pharmacoeconomic evaluations, particularly in low- and middle-income countries (LMICs) where medication expenses can dominate healthcare budgets ...
Rania Indu, Moumita Ray, Sudipto Mangal
doaj
Pharmacoeconomics of Bronchial Asthma
Folia Medica, 2019 Introduction: Pharmacoeconomics (PE) treats the problems of pharmacotherapy policy, drug marketing and reimbursement and clinical trials. It guides policy makers for effective health resources utilization and determines the profitability of the new drugs
Ivanova Zlatina I., Ivanov Yavor Y.
doaj +1 more source
Biology of Blood and Marrow Transplantation, 2013 Adequate hematopoietic stem cell (HSC) mobilization and collection is required prior to proceeding with high dose chemotherapy and autologous hematopoietic stem cell transplant. Cytokines such as G-CSF, GM-CSF, and peg-filgrastim, alone or in combination
P. Shaughnessy +10 more
semanticscholar +1 more source
Development and validation of the Chinese patient-centered integrated care scale
BMC Health Services ResearchBackground The healthcare system is currently facing challenges in transitioning to a more integrated, patient-centered care. China has implemented various practical exploration and pilot programs in developing an integrated healthcare service system ...
Yue Yin +3 more
doaj +1 more source
PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
Кардиоваскулярная терапия и профилактика, 2015 Eplerenone (Inspra, Pfizer) improves the prognosis of patients with chronic heart failure and heart failure after acute myocardial infarction. Since Russia eplerenone pharmacoeconomics issues rarely discussed, the analysis of the literature on this topic
Yu. M. Lopatin, E. Yu. Lopatina
doaj +1 more source
Pharmacoeconomics of HIV-infection
Регуляторные исследования и экспертиза лекарственных средств, 2018 Ever since the first registrations of HIV-infections at the territory of the Russian Federation there was started a great process on arrangement and, subsequently, development of anti-HIV system.
R. I. Yagudina +3 more
doaj
Multidisciplinary Respiratory Medicine, 2018 After publication of the Original research article [1] it was brought to our attention that the sentence at pag 6 (between Figure 3 and Figure 4)) must be corrected as follows: “The mean duration of inactivity was 2.88 (0.63) at baseline; 1.53 (0.27 ...
Roberto W. Dal Negro +2 more
doaj +1 more source